Kaden, Tim
Graf, Katja
Rennert, Knut
Li, Ruoya
Mosig, Alexander S.
Raasch, Martin
Funding for this research was provided by:
Thüringer Aufbaubank (2019 SU 0128)
Article History
Received: 18 November 2022
Accepted: 3 August 2023
First Online: 16 August 2023
Competing interests
: M.R., K.R. hold equity in Dynamic42 GmbH. A.S.M. holds equity in and consults Dynamic42 GmbH. R.Y.L. provided HepaRG cells. T.K. and K.G. have no conflict of interest.